Please select the option that best describes you:
In a patient with low-risk papillary thyroid carcinoma in 1 thyroid lobe s/p hemithyroidectomy, how would a diagnosis of Graves' orbitopathy (euthyroid biochemically) affect your classification and TSH target for thyroid-cancer treatment?
Conflicting data exists on whether Graves' disease would increase the aggressiveness of the concomitant thyroid cancer vs having no effect/correlation.
Answer from: at Academic Institution
Clinical information that would be useful include age, size of the tumor, tumor histology, presence or absence of ETE, angioinvasion, molecular marker profile (if performed) and lymph node status. Also important would be TSI and TRAB status.
Directions and thoughts regarding optimal TSH level...
Sign in or Register to read more